Matches in Nanopublications for { ?s ?p "[Results from this study demonstrate synergistic antiproliferative effects in response to the combination of OSI-906 with an MEK 1/2 inhibitor in colorectal cancer cell line models both in vitro and in vivo, which supports the rational combination of OSI-906 with an MEK inhibitor in patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP645822.RAfkDqd-tt7I0gFLmpNVxmxIQOM2Na3buLBC4tjTH2BlM130_assertion description "[Results from this study demonstrate synergistic antiproliferative effects in response to the combination of OSI-906 with an MEK 1/2 inhibitor in colorectal cancer cell line models both in vitro and in vivo, which supports the rational combination of OSI-906 with an MEK inhibitor in patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645822.RAfkDqd-tt7I0gFLmpNVxmxIQOM2Na3buLBC4tjTH2BlM130_provenance.
- NP646210.RAUvVel0NtJU3pBqG6A-F8jsQzFCvXdp1_evDGlRF8Z74130_assertion description "[Results from this study demonstrate synergistic antiproliferative effects in response to the combination of OSI-906 with an MEK 1/2 inhibitor in colorectal cancer cell line models both in vitro and in vivo, which supports the rational combination of OSI-906 with an MEK inhibitor in patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646210.RAUvVel0NtJU3pBqG6A-F8jsQzFCvXdp1_evDGlRF8Z74130_provenance.
- NP646495.RAQ_MRoWrN0J06OrMKnrwC6loKKKFuXjcGcpb_YT7ii1E130_assertion description "[Results from this study demonstrate synergistic antiproliferative effects in response to the combination of OSI-906 with an MEK 1/2 inhibitor in colorectal cancer cell line models both in vitro and in vivo, which supports the rational combination of OSI-906 with an MEK inhibitor in patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646495.RAQ_MRoWrN0J06OrMKnrwC6loKKKFuXjcGcpb_YT7ii1E130_provenance.
- NP1111628.RAdGtNHMULHvPskh9RqtvLCye7CTayafDmz7R6oCRaZkM130_assertion description "[Results from this study demonstrate synergistic antiproliferative effects in response to the combination of OSI-906 with an MEK 1/2 inhibitor in colorectal cancer cell line models both in vitro and in vivo, which supports the rational combination of OSI-906 with an MEK inhibitor in patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111628.RAdGtNHMULHvPskh9RqtvLCye7CTayafDmz7R6oCRaZkM130_provenance.
- NP1111632.RAdqenILirETw7QQUj0BUEFNj_avNbnq1nP1WpK9kRXfM130_assertion description "[Results from this study demonstrate synergistic antiproliferative effects in response to the combination of OSI-906 with an MEK 1/2 inhibitor in colorectal cancer cell line models both in vitro and in vivo, which supports the rational combination of OSI-906 with an MEK inhibitor in patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111632.RAdqenILirETw7QQUj0BUEFNj_avNbnq1nP1WpK9kRXfM130_provenance.
- NP645988.RAK0MML5dImP9oyh4PQGkUv_jYxNirV1g_NGVB_atTDbo130_assertion description "[Results from this study demonstrate synergistic antiproliferative effects in response to the combination of OSI-906 with an MEK 1/2 inhibitor in colorectal cancer cell line models both in vitro and in vivo, which supports the rational combination of OSI-906 with an MEK inhibitor in patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645988.RAK0MML5dImP9oyh4PQGkUv_jYxNirV1g_NGVB_atTDbo130_provenance.
- NP1111629.RA2FrBMJgXToYVzrfk7s_ys82N0QbexGf2jDU7F4SZNok130_assertion description "[Results from this study demonstrate synergistic antiproliferative effects in response to the combination of OSI-906 with an MEK 1/2 inhibitor in colorectal cancer cell line models both in vitro and in vivo, which supports the rational combination of OSI-906 with an MEK inhibitor in patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111629.RA2FrBMJgXToYVzrfk7s_ys82N0QbexGf2jDU7F4SZNok130_provenance.
- NP1111635.RA6gkrJwUtPiWEOnSpFu7gfdxfc8J4sksNEqehJdvJ-pc130_assertion description "[Results from this study demonstrate synergistic antiproliferative effects in response to the combination of OSI-906 with an MEK 1/2 inhibitor in colorectal cancer cell line models both in vitro and in vivo, which supports the rational combination of OSI-906 with an MEK inhibitor in patients with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111635.RA6gkrJwUtPiWEOnSpFu7gfdxfc8J4sksNEqehJdvJ-pc130_provenance.